Cosmo Pharmaceuticals NV
F:C43
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cosmo Pharmaceuticals NV
F:C43
|
IE |
|
R
|
RAM Essential Services Property Fund
ASX:REP
|
AU |
|
Capital Ltd
LSE:CAPD
|
MU |
|
Environmental Tectonics Corp
OTC:ETCC
|
US |
|
Sparebanken More
OSE:MORG
|
NO |
|
M
|
Matsa Resources Ltd
DUS:KB2
|
AU |
|
Energia Innovacion y Desarrollo Fotovoltaico SA
MAD:EIDF
|
ES |
|
Mcf Energy Ltd
F:DC6
|
CA |
|
M
|
Mercury Systems Inc
F:MCY
|
US |
|
O
|
Orosur Mining Inc
F:UR2
|
CA |
|
O
|
Onward Technologies Ltd
BSE:517536
|
IN |
|
TherapeuticsMD Inc
NASDAQ:TXMD
|
US |
|
Seplat Energy PLC
F:134
|
NG |
|
Cosa Resources Corp
F:SSKU
|
CA |
|
F
|
FirstGroup PLC
SWB:FGR
|
UK |
|
Unilever Indonesia Tbk PT
IDX:UNVR
|
ID |
|
Z
|
ZIGUP PLC
F:21W
|
UK |
|
E
|
Evd Bhd
KLSE:EVD
|
MY |
|
Otello Corporation ASA
OTC:OPESF
|
NO |
|
American Battery Materials Inc
OTC:BLTH
|
US |
|
Celldex Therapeutics Inc
NASDAQ:CLDX
|
US |
|
C
|
Cathay Pacific Airways Ltd
XMUN:CTY
|
HK |
|
Stitch Fix Inc
NASDAQ:SFIX
|
US |
|
F
|
Frigoglass SAIC
ATHEX:FRIGO
|
GR |
Bankruptcy Probability
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cosmo Pharmaceuticals NV Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IE |
|
Cosmo Pharmaceuticals NV
SIX:CMHC
|
812.8m CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
617.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
351.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
346.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
223.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
186.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
324.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
121.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cosmo Pharmaceuticals NV's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cosmo Pharmaceuticals NV has total debt of 3.6m EUR. This includes both short-term (0 EUR) and long-term (3.6m EUR) debt.
You can find a full breakdown on its Balance Sheet.